Oncolytic Adenovirus Market Overview 2025: Size, Share & Growth Analysis

29 Apr, 2025

The Oncolytic Adenovirus Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.

What are the Historical Growth Trends in the Oncolytic Adenovirus Market?

The market size of oncolytic adenovirus has significantly expanded over the past years. The market is projected to rise from $122.31 billion in 2024 to $132.87 billion in 2025, with a compound annual growth rate (CAGR) of 8.6%.

What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Oncolytic Adenovirus Industry?

The global market for oncolytic adenovirus is forecasted to reach a size of $183.22 billion by the year 2029, growing at a compound annual growth rate (CAGR) of 8.4%.

Download Your Free Sample of the 2025 Oncolytic Adenovirus Market Report and Uncover Key Trends Now!

What are the Key Growth Drivers Fueling the Oncolytic Adenovirus Market?

The key drivers in the oncolytic adenovirus market are:

• Rising prevalence and incidence of cancer
• Expansion of combination therapies for treatment
• Technological advancements in virus engineering
• Increased investment in oncology research

Global Market Segmentation: Identifying Major Oncolytic Adenovirus Industry Segments

The oncolytic adenovirus market covered in this report is segmented –
1) By Virus Type: Adenovirus Type 5-Based Oncolytic Viruses, Adenovirus Type 2-Based Oncolytic Viruses, Other Virus Types
2) By Application: Melanoma, Prostate Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Other Applications
3) By End-User: Hospitals, Cancer Research Institutes, Biotechnology Companies, Academic And Research Institutes Subsegments:
1) By Adenovirus Type 5-Based Oncolytic Viruses: First-generation Adenovirus Type 5-based, Second-generation Adenovirus Type 5-based, Engineered Adenovirus Type 5-based
2) By Adenovirus Type 2-Based Oncolytic Viruses: First-generation Adenovirus Type 2-based, Second-generation Adenovirus Type 2-based, Engineered Adenovirus Type 2-based
3) By Other Virus Types: Modified Adenovirus Strains, Hybrid Adenovirus Types, Chimeric Adenoviruses

Pre-order the 2025 Oncolytic Adenovirus Global Market Report for Fast Delivery & Comprehensive Insights!

What are the emerging Trends Shaping the Future of the Oncolytic Adenovirus Market?

The key trends in the oncolytic adenovirus market are:

• Advancements in viral engineering techniques are shaping the future of the market.
• The advancement of drug delivery systems is an emerging trend.
• Enhancements in tumor targeting precision is a significant up and coming direction.
• Progress in immunotherapy combinations is becoming a prominent trend.

Who Are the Top Competitors & Leading Players in the Oncolytic Adenovirus Market?

Major players in the oncolytic adenovirus market are:

• Amgen Inc.
• Targovax ASA
• CG Oncology Inc.
• Replimune Group Inc.
• Imugene Limited
• Oncorus Inc.
• PsiOxus Therapeutics Ltd.
• Vyriad Inc.
• Transgene SA
• Valo Therapeutics Oy
• EpicentRx Inc.
• DNAtrix Inc.
• Shanghai Sunway Biotech Co. Ltd.
• TILT Biotherapeutics Ltd.
• Oncolys BioPharma Inc.
• Lokon Pharma AB
• GeneMedicine Co. Ltd.
• Akamis Bio Ltd.
• Genelux Corporation
• SillaJen Inc.

Regional Dominance: Which Area Leads the Global Template Market?

North America was the largest region in the oncolytic adenovirus market in 2024